-
-
-
-
-
-
-
KeyBanc Reiterates Overweight Rating on Castle Biosciences (CSTL) as 'TissueCypher Gains Momentum'
-
-
-
-
-
-
-
Castle Biosciences Reports Second Quarter 2024 Results
-
-
-
-
-
-
-
Castle Biosciences Reports Second Quarter 2023 Results
-
-
-
-
-
-
-
Castle Biosciences Reports First Quarter 2022 Results
-
-
-
-
-
-
-
Castle Biosciences Completes Acquisition of Cernostics
-
-
-
-
-
-
-
Castle Biosciences Announces Second Quarter 2021 Results
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

